// App-Quantinova.ai

196 : The Effect of Administration Route for Osteoporosis Therapy on the Fracture-to-Fall Ratio

Researchers

Presenter

  • Richard Tse

Principal Investigators

  • Wojciech Olszynski

Medical Centers

  • University of Saskatchewan, Saskatoon, SK, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoporosis

Biomarkers

  • N/A

Drug/Treatment

  • Zoledronic acid

  • Hydroxyzine

  • Denosumab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved